The presence of human papillomavirus type 16/18 DNA in blood circulation may act as a risk marker of lung cancer in Taiwan

Hui Ling Chiou, Ming Fang Wu, Yu Ching Liaw, Ya Wen Cheng, Ruey Hong Wong, Chin Yi Chen, Huei Lee

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

BACKGROUND. Lung cancer is the leading cause of cancer death in Taiwan, and the paucity of dependable risk markers has impeded the early management of lung cancer. An association of human papillomavirus (HPV) 16/18 infection with lung cancer among nonsmoking Taiwanese women was revealed in our previous study. METHODS. Nested PCR was employed to detect HPV 16/18 DNA in the blood circulation of 149 lung cancer patients and 174 noncancer controls. In addition, correlation of prevalence of HPV DNA between the blood circulation and lung tumor tissue was compared from 70 sets of paired tumor tissues and peripheral blood samples available. RESULTS. The results showed that the prevalence rate of HPV 16/18 in the blood circulation of lung cancer cases was significantly higher than that of noncancer controls (47.7% vs. 12.6% for HPV 16, P <0.0001; 30.9% vs. 5.2% for HPV 18, P <0.0001). A significantly higher HPV 16 prevalence was detected in female lung cancer patients than that of male (57.6% vs. 41.1%, P = 0.048), as well as in cases with tumor Stages III/IV than those with tumor Stages I/II (54.6% vs. 29.3%, P = 0.006). After adjusting the effects of age, gender, and smoking status, a 6.5-fold greater risk of lung cancer was demonstrated for those subjects with HPV Type 16 positive (95% CI 3.7-11.3, P <0.0001), a 9.2-fold for HPV Type 18 positive (95% CI 4.2-20.2, P <0.0001), and a 75.7-fold greatest risk for those with both HPV Type 16 and 18 positive (95% CI 9.8-582.1, P <0.0001). CONCLUSIONS. These results suggested that the presence of HPV DNA in the blood circulation may serve as a feasible risk marker of lung cancer.

Original languageEnglish
Pages (from-to)1558-1563
Number of pages6
JournalCancer
Volume97
Issue number6
DOIs
Publication statusPublished - Mar 15 2003
Externally publishedYes

Fingerprint

Human papillomavirus 18
Human papillomavirus 16
Blood Circulation
Taiwan
Lung Neoplasms
DNA
Neoplasms
Cause of Death
Smoking
Polymerase Chain Reaction
Lung

Keywords

  • Blood circulation
  • Cancerous tissue
  • Human papillomavirus
  • Lung cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Chiou, H. L., Wu, M. F., Liaw, Y. C., Cheng, Y. W., Wong, R. H., Chen, C. Y., & Lee, H. (2003). The presence of human papillomavirus type 16/18 DNA in blood circulation may act as a risk marker of lung cancer in Taiwan. Cancer, 97(6), 1558-1563. https://doi.org/10.1002/cncr.11191

The presence of human papillomavirus type 16/18 DNA in blood circulation may act as a risk marker of lung cancer in Taiwan. / Chiou, Hui Ling; Wu, Ming Fang; Liaw, Yu Ching; Cheng, Ya Wen; Wong, Ruey Hong; Chen, Chin Yi; Lee, Huei.

In: Cancer, Vol. 97, No. 6, 15.03.2003, p. 1558-1563.

Research output: Contribution to journalArticle

Chiou, HL, Wu, MF, Liaw, YC, Cheng, YW, Wong, RH, Chen, CY & Lee, H 2003, 'The presence of human papillomavirus type 16/18 DNA in blood circulation may act as a risk marker of lung cancer in Taiwan', Cancer, vol. 97, no. 6, pp. 1558-1563. https://doi.org/10.1002/cncr.11191
Chiou, Hui Ling ; Wu, Ming Fang ; Liaw, Yu Ching ; Cheng, Ya Wen ; Wong, Ruey Hong ; Chen, Chin Yi ; Lee, Huei. / The presence of human papillomavirus type 16/18 DNA in blood circulation may act as a risk marker of lung cancer in Taiwan. In: Cancer. 2003 ; Vol. 97, No. 6. pp. 1558-1563.
@article{37cdce758a3749f4bd2d9aaa0bda3c80,
title = "The presence of human papillomavirus type 16/18 DNA in blood circulation may act as a risk marker of lung cancer in Taiwan",
abstract = "BACKGROUND. Lung cancer is the leading cause of cancer death in Taiwan, and the paucity of dependable risk markers has impeded the early management of lung cancer. An association of human papillomavirus (HPV) 16/18 infection with lung cancer among nonsmoking Taiwanese women was revealed in our previous study. METHODS. Nested PCR was employed to detect HPV 16/18 DNA in the blood circulation of 149 lung cancer patients and 174 noncancer controls. In addition, correlation of prevalence of HPV DNA between the blood circulation and lung tumor tissue was compared from 70 sets of paired tumor tissues and peripheral blood samples available. RESULTS. The results showed that the prevalence rate of HPV 16/18 in the blood circulation of lung cancer cases was significantly higher than that of noncancer controls (47.7{\%} vs. 12.6{\%} for HPV 16, P <0.0001; 30.9{\%} vs. 5.2{\%} for HPV 18, P <0.0001). A significantly higher HPV 16 prevalence was detected in female lung cancer patients than that of male (57.6{\%} vs. 41.1{\%}, P = 0.048), as well as in cases with tumor Stages III/IV than those with tumor Stages I/II (54.6{\%} vs. 29.3{\%}, P = 0.006). After adjusting the effects of age, gender, and smoking status, a 6.5-fold greater risk of lung cancer was demonstrated for those subjects with HPV Type 16 positive (95{\%} CI 3.7-11.3, P <0.0001), a 9.2-fold for HPV Type 18 positive (95{\%} CI 4.2-20.2, P <0.0001), and a 75.7-fold greatest risk for those with both HPV Type 16 and 18 positive (95{\%} CI 9.8-582.1, P <0.0001). CONCLUSIONS. These results suggested that the presence of HPV DNA in the blood circulation may serve as a feasible risk marker of lung cancer.",
keywords = "Blood circulation, Cancerous tissue, Human papillomavirus, Lung cancer",
author = "Chiou, {Hui Ling} and Wu, {Ming Fang} and Liaw, {Yu Ching} and Cheng, {Ya Wen} and Wong, {Ruey Hong} and Chen, {Chin Yi} and Huei Lee",
year = "2003",
month = "3",
day = "15",
doi = "10.1002/cncr.11191",
language = "English",
volume = "97",
pages = "1558--1563",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - The presence of human papillomavirus type 16/18 DNA in blood circulation may act as a risk marker of lung cancer in Taiwan

AU - Chiou, Hui Ling

AU - Wu, Ming Fang

AU - Liaw, Yu Ching

AU - Cheng, Ya Wen

AU - Wong, Ruey Hong

AU - Chen, Chin Yi

AU - Lee, Huei

PY - 2003/3/15

Y1 - 2003/3/15

N2 - BACKGROUND. Lung cancer is the leading cause of cancer death in Taiwan, and the paucity of dependable risk markers has impeded the early management of lung cancer. An association of human papillomavirus (HPV) 16/18 infection with lung cancer among nonsmoking Taiwanese women was revealed in our previous study. METHODS. Nested PCR was employed to detect HPV 16/18 DNA in the blood circulation of 149 lung cancer patients and 174 noncancer controls. In addition, correlation of prevalence of HPV DNA between the blood circulation and lung tumor tissue was compared from 70 sets of paired tumor tissues and peripheral blood samples available. RESULTS. The results showed that the prevalence rate of HPV 16/18 in the blood circulation of lung cancer cases was significantly higher than that of noncancer controls (47.7% vs. 12.6% for HPV 16, P <0.0001; 30.9% vs. 5.2% for HPV 18, P <0.0001). A significantly higher HPV 16 prevalence was detected in female lung cancer patients than that of male (57.6% vs. 41.1%, P = 0.048), as well as in cases with tumor Stages III/IV than those with tumor Stages I/II (54.6% vs. 29.3%, P = 0.006). After adjusting the effects of age, gender, and smoking status, a 6.5-fold greater risk of lung cancer was demonstrated for those subjects with HPV Type 16 positive (95% CI 3.7-11.3, P <0.0001), a 9.2-fold for HPV Type 18 positive (95% CI 4.2-20.2, P <0.0001), and a 75.7-fold greatest risk for those with both HPV Type 16 and 18 positive (95% CI 9.8-582.1, P <0.0001). CONCLUSIONS. These results suggested that the presence of HPV DNA in the blood circulation may serve as a feasible risk marker of lung cancer.

AB - BACKGROUND. Lung cancer is the leading cause of cancer death in Taiwan, and the paucity of dependable risk markers has impeded the early management of lung cancer. An association of human papillomavirus (HPV) 16/18 infection with lung cancer among nonsmoking Taiwanese women was revealed in our previous study. METHODS. Nested PCR was employed to detect HPV 16/18 DNA in the blood circulation of 149 lung cancer patients and 174 noncancer controls. In addition, correlation of prevalence of HPV DNA between the blood circulation and lung tumor tissue was compared from 70 sets of paired tumor tissues and peripheral blood samples available. RESULTS. The results showed that the prevalence rate of HPV 16/18 in the blood circulation of lung cancer cases was significantly higher than that of noncancer controls (47.7% vs. 12.6% for HPV 16, P <0.0001; 30.9% vs. 5.2% for HPV 18, P <0.0001). A significantly higher HPV 16 prevalence was detected in female lung cancer patients than that of male (57.6% vs. 41.1%, P = 0.048), as well as in cases with tumor Stages III/IV than those with tumor Stages I/II (54.6% vs. 29.3%, P = 0.006). After adjusting the effects of age, gender, and smoking status, a 6.5-fold greater risk of lung cancer was demonstrated for those subjects with HPV Type 16 positive (95% CI 3.7-11.3, P <0.0001), a 9.2-fold for HPV Type 18 positive (95% CI 4.2-20.2, P <0.0001), and a 75.7-fold greatest risk for those with both HPV Type 16 and 18 positive (95% CI 9.8-582.1, P <0.0001). CONCLUSIONS. These results suggested that the presence of HPV DNA in the blood circulation may serve as a feasible risk marker of lung cancer.

KW - Blood circulation

KW - Cancerous tissue

KW - Human papillomavirus

KW - Lung cancer

UR - http://www.scopus.com/inward/record.url?scp=0037443752&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037443752&partnerID=8YFLogxK

U2 - 10.1002/cncr.11191

DO - 10.1002/cncr.11191

M3 - Article

C2 - 12627521

AN - SCOPUS:0037443752

VL - 97

SP - 1558

EP - 1563

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 6

ER -